Eton Pharmaceuticals Inc Cash Flow Reinvestment Rate
Eton Pharmaceuticals Inc cash flow reinvestment rate. Eton Pharmaceuticals Inc (ETON) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $5.00K (capex $5.00K ) from operating cash flow of $7.25 Million. Explore Eton Pharmaceuticals Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Eton Pharmaceuticals Inc (2022–2025)
Cash flow reinvestment rate of Eton Pharmaceuticals Inc from 2022 to 2025. Historical reinvestment intensity for Eton Pharmaceuticals Inc across 4 annual periods. Explore capital reinvestment ratio of Eton Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Eton Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2022–2025)
Eton Pharmaceuticals Inc cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for Eton Pharmaceuticals Inc. For the full cash flow conversion analysis, see Eton Pharmaceuticals Inc (ETON) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | $333.00K | $10.52 Million | $333.00K | ▼ -99.9% |
| 2024 | 41.32x | $40.04 Million | $969.00K | $26.00K | ▲ +18067.9% |
| 2023 | 0.23x | $1.55 Million | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 1.16x | $5.58 Million | $4.82 Million | $2.79 Million | — |